| |
| |
|
| Insider
Information: |
Lim Jonathan E |
| Relationship: |
|
| City: |
San Diego, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
812,564 |
|
|
Indirect Shares
|
32,906,491 |
|
|
| Direct
Value |
$33,460,578 |
|
|
|
Indirect Value
|
$82,090,159 |
|
|
| Total
Shares |
33,719,055 |
|
|
| Total
Value |
$115,550,738 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -18.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
Chief Executive Office... |
2010-01-12 |
710,000 |
|
0 |
Premium* |
|
|
Erasca, Inc. |
ERAS |
Chairman & CEO, Direct... |
2022-12-14 |
0 |
2023-12-06 |
32,355,576 |
Premium* |
|
|
Boundless Bio, Inc. |
BOLD |
|
2024-04-02 |
102,564 |
2024-04-02 |
550,915 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2023-01-10 |
4 |
B |
$3.86 |
$231,420 |
I/I |
60,000 |
20,256,222 |
2.64 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2007-06-25 |
4 |
OE |
$0.39 |
$37,562 |
D/D |
96,313 |
673,310 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and C. E. O. |
• • – |
2005-03-24 |
4 |
OE |
$0.39 |
$39,000 |
D/D |
100,000 |
589,497 |
|
- |
|
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2023-03-28 |
4 |
B |
$2.84 |
$284,000 |
I/I |
100,000 |
18,296,216 |
2.64 |
% |
|
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2023-06-08 |
4 |
B |
$2.75 |
$275,000 |
I/I |
100,000 |
18,396,216 |
2.64 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2008-03-19 |
4 |
OE |
$0.39 |
$89,700 |
D/D |
230,000 |
930,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President, CEO |
• • – |
2008-03-20 |
4 |
S |
$6.06 |
$1,515,000 |
D/D |
(250,000) |
680,000 |
0 |
- |
|
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2023-12-06 |
4 |
B |
$1.72 |
$478,418 |
I/I |
278,150 |
12,899,360 |
2.64 |
% |
|
| BOLD |
Boundless Bio, Inc. |
|
– • – |
2024-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
525,274 |
550,915 |
0 |
- |
|
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2023-12-05 |
4 |
B |
$1.69 |
$1,217,761 |
I/I |
721,850 |
12,899,360 |
2.64 |
% |
|
| ERAS |
Erasca, Inc. |
Chairman & CEO |
• • • |
2023-10-05 |
4 |
B |
$2.03 |
$2,026,000 |
I/I |
1,000,000 |
19,456,216 |
2.64 |
% |
|
36 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
